Boston Biomedical Associates -BBA- To Co-Sponsor Medtech Insight's ''In Circulation'' Conference.

CHICAGO -- Boston Biomedical Associates, a premier regulatory and clinical research consulting firm, has announced its co-sponsorship of Medtech Insight's prestigious "In Circulation: Strategic Partnering and Investing in Circulatory Medicine" Conference, taking place April 27, 2005 at the Hyatt Regency McCormick Place in Chicago, IL.

This premier strategic partnering and investment meeting for medical technology will feature presentations by over 35 innovative device companies focused on emerging cardiovascular/neurovascular/peripheral vascular technologies. The conference will provide professionals from the investment community and major medical technology, biopharmaceutical, and biotech companies unique business opportunities and partnerships through breakout sessions and exhibits which follow the company presentations.

"This conference provides an excellent opportunity for BBA, as a sponsor, to present its regulatory and clinical research expertise in the cardiovascular, neurovascular, and peripheral vascular arenas", commented Leo Basta, founding partner of BBA. "We are delighted to partner with Medtech Insight at this unique forum that fosters networking with the investment and biotech communities seeking insight into emerging vascular technologies."

Boston Biomedical Associates (BBA)

BBA provides medical device and biomedical companies with comprehensive, proven methodologies to help bring new technologies to market more efficiently and with total quality assurance. At this meeting, BBA will introduce its proprietary Med-D4 program which addresses the many challenges associated with bringing new technology to market and provides strategic solutions to help accelerate time to market. Med-D4 is designed to:

--define regulatory and clinical strategies

--develop clinical research and data management processes

--document the submission process

--deliver the product approval process

In addition to regulatory, clinical research, and quality assurance services, Boston Biomedical Associates also provides a wide range of services to the venture capital community including technology evaluations, facilitation of due diligence activities, and FDA approval process consultation and management.

Imaging Core Lab Services (ICLS)

BBA's sister company, Imaging Core Lab Services (ICLS), also represented at the conference, provides complete core imaging analysis and management services for measuring anatomic effects of therapeutics and devices--processes often required to support clinical trial claims. "We differentiate ourselves from other core labs in that we provide not only image analysis but also complete project management," said Dr. Bonnie Weiner, President and Medical Director of ICLS. "Our efficient web-based tracking system, direct investigator interfacing, and comprehensive project management helps keep critical core lab projects on-track, on-time, and on-budget."

For more information on Boston Biomedical Associates and Imaging Core Lab Services, please visit the companies' websites at: www.boston-biomedical.com and www.icls.us.

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. To register for the "In Circulation" conference or for more information on Medtech Insight, please call Scott Pantel at [phone] or [phone] toll-free in the U.S., e-mail [e-mail], or visit www.medtechinsight.com.